A recent Morbidity and Mortality Weekly Report (MMWR) highlights the risks associated with use of over-the-counter (OTC) products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.
By watching what they eat and drink, patients can control such common problems as overactive bladder, prostatitis, interstitial cystitis, and chronic kidney disease.
Erectile function improved significantly among men with ED in the placebo arms of clinical trials of phosphodiesterase 5 inhibitors, especially among those with posttraumatic stress disorder, a meta-analysis revealed.
Investigators found a significant positive correlation between transitional zone index (TZI) and IPSS and a significant negative correlation between TZI and both the International Index of Erectile Function and penile peak systolic velocity.
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
In a meta-analysis, cannabis smokers had a 4-fold higher risk for erectile dysfunction than nonusers.
Greater ED severity associated with worse outcomes for men worldwide
A study of former US professional football players found that the risk of self-reported indicators of low testosterone and erectile dysfunction increased with each successive quartile of concussion symptom score.
In a randomized, double-blind trial, short-term atorvastatin use before to radical prostatectomy did not improve postoperative erectile function compared with placebo.
In a prospective trial of men with erectile dysfunction and lower urinary tract symptoms, tadalafil plus tamsulosin achieved greater improvements in maximum urinary flow rates and voiding symptoms.
